ResMed, Inc. (RMD) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $228.35 -0.37%
Revenue Growth %: +6.9%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +6.9%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $349.1 million versus the consensus estimate of $339.56 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
